Biosolution Co., Ltd. has completed an IPO in the amount of KRW 43.5 billion.

Bio Solution Co.,Ltd. is a Korea based company mainly engaged in the manufacturing and distribution of cell therapy products. The Company manufactures and sells cell based cosmetic raw materials and therapeutics with background in somatic and stem cell technology. The Company’s major products include cosmetic raw material called stem water, which contains human stem cells has whitening and anti-wrinkling effects; as well as keratinocyte medication for severe burns and chondrocyte therapy product used to cure arthritis. The Company also researches and develops human tissue models for toxicity and efficacy testing using tissue engineering technology.